Computerized Neuropsychology in Idiopathic Normal Pressure Hydrocephalus (INPH)

Sponsor
Umeå University (Other)
Overall Status
Completed
CT.gov ID
NCT01265251
Collaborator
(none)
97
1
32
3

Study Details

Study Description

Brief Summary

A computerised neuropsychological test battery to be used as a standardised tool assessing the cognitive domains affected by idiopathic normal pressure hydrocephalus INPH was developed. The aim of this study is to investigate the reliability, validity and feasibility of the battery.

Condition or Disease Intervention/Treatment Phase
  • Device: Computerized neuropsychological test
  • Other: Conventional neuropsychological test

Study Design

Study Type:
Observational
Actual Enrollment :
97 participants
Time Perspective:
Cross-Sectional
Official Title:
Evaluation of a Computerised Neuropsychological Test Battery for Idiopathic Normal Pressure Hydrocephalus (INPH)
Study Start Date :
Aug 1, 2007
Actual Primary Completion Date :
Apr 1, 2010
Actual Study Completion Date :
Apr 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Test-retest

Forty-four healthy elderly 60-82 years old

Device: Computerized neuropsychological test
Computerized neuropsychological test battery.

Validity

Twenty six patients with various diseases and various ages

Device: Computerized neuropsychological test
Computerized neuropsychological test battery.

Other: Conventional neuropsychological test
Conventional neuropsychological test (paper and pen)

Feasibility

Twenty seven patients under the preoperative investigation for INPH

Device: Computerized neuropsychological test
Computerized neuropsychological test battery.

Outcome Measures

Primary Outcome Measures

  1. Validity [Within 24 h]

    Computerized test battery and equivalent standard neuropsychological test battery is given to the same subject. Correlation between paper and pen and equivalent computerized test is calculated as a validity measure.

  2. Reliability [More than 7 days, within 2 months]

    The computerized test battery is given to the same subject twice. Correlation between the two tests is calculated as a test-retest reliability measure.

  3. Feasibility [Within 24 h]

    Patients under the investigation for INPH are given the computerized test battery. Number of patients who manage to complete the test is the feasibility measure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Probable INPH under investigation

  • Healthy elderly

  • Various diseases

Exclusion Criteria:
  • (Healthy elderly) medications affecting nervous system

  • (Healthy elderly)heart disease

  • (Healthy elderly)diabetes

  • (Healthy elderly)disease of the nervous system

  • (Healthy elderly)MMSE < 28

  • (Healthy elderly)vascular risk factors (Two of: 1 hypertension, 2 smoking or 3 hyperlipidemia)

  • (Healthy elderly)serious disease that may shorten life expectancy

  • (Various diseases) Affected motor functions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Neuroscience Umeå Västerbotten Sweden SE-901 85

Sponsors and Collaborators

  • Umeå University

Investigators

  • Principal Investigator: Anders Behrens, M.D., M.Sc., Department of Clinical Neuroscience

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01265251
Other Study ID Numbers:
  • 07-088M
First Posted:
Dec 23, 2010
Last Update Posted:
Dec 23, 2010
Last Verified:
Dec 1, 2010

Study Results

No Results Posted as of Dec 23, 2010